Scholar Rock Holding Corporation

NASDAQ:SRRK

8.03 (USD) • At close September 6, 2024
Bedrijfsnaam Scholar Rock Holding Corporation
Symbool SRRK
Munteenheid USD
Prijs 8.03
Beurswaarde 642,661,778
Dividendpercentage 0%
52-weken bereik 5.94 - 21.17
Industrie Biotechnology
Sector Healthcare
CEO Dr. Jay T. Backstrom M.D., M.P.H.
Website https://scholarrock.com

An error occurred while fetching data.

Over Scholar Rock Holding Corporation

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3

Vergelijkbare Aandelen

Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc.

RPID

0.835 USD

Harrow Health, Inc. logo

Harrow Health, Inc.

HROW

37.98 USD

Tactile Systems Technology, Inc. logo

Tactile Systems Technology, Inc.

TCMD

13.2 USD

Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc.

ORMP

2.35 USD

Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

LYRA

0.273 USD

Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI

33.4 USD

Personalis, Inc. logo

Personalis, Inc.

PSNL

5.37 USD

Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc.

VKTX

54.13 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)